Celltrion Pharm Inc. | |
Stock Exchange | Korea Exchange |
EPS |
KRW204.41 |
Market Cap |
KRW2.72 T |
Shares Outstanding |
34.04 M |
Public Float |
15.23 M |
Address |
82 2sandan-ro Cheongju-si NC 28117 Korea, Republic Of |
Employees | - |
Website | http://www.celltrionph.com |
Updated | 09/14/2018 |
Celltrion Pharm, Inc. engages in the manufacture and sale of pharmaceuticals. Its products are categorized into the following: the group of medicine effect, biosimilars and over-the-counter (OTC) drug. The group of medicine effect includes hepatotonics, hepatotonics and anti-inflammatory drugs, antihistamine, respiratory apparatus drugs, circulatory system drug, digestives and stomachics drug, hormone and metabolic disease drugs, antibiotics and antimycotic, nutrientia and tonic, immunology, oncology, and the other drugs. |